These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14621103)

  • 61. Low-Flow Domiciliary Oxygen as a Mechanism of Ongoing Oxidative Stress.
    Stulce JM; Biddle C; Vacchiano C
    Respir Care; 2019 Nov; 64(11):1387-1391. PubMed ID: 30837329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
    Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
    Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does oxidative stress modulate limb muscle atrophy in severe COPD patients?
    Fermoselle C; Rabinovich R; Ausín P; Puig-Vilanova E; Coronell C; Sanchez F; Roca J; Gea J; Barreiro E
    Eur Respir J; 2012 Oct; 40(4):851-62. PubMed ID: 22408199
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?
    Koechlin C; Couillard A; Cristol JP; Chanez P; Hayot M; Le Gallais D; Préfaut C
    Eur Respir J; 2004 Apr; 23(4):538-44. PubMed ID: 15083751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases.
    Rahman I
    J Biochem Mol Biol; 2003 Jan; 36(1):95-109. PubMed ID: 12542980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxidative, inflammatory, genetic, and epigenetic biomarkers associated with chronic obstructive pulmonary disorder.
    Aggarwal T; Wadhwa R; Thapliyal N; Sharma K; Rani V; Maurya PK
    J Cell Physiol; 2019 Mar; 234(3):2067-2082. PubMed ID: 30171697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The mechanisms of cachexia underlying muscle dysfunction in COPD.
    Remels AH; Gosker HR; Langen RC; Schols AM
    J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review.
    Zinellu E; Zinellu A; Fois AG; Carru C; Pirina P
    Respir Res; 2016 Nov; 17(1):150. PubMed ID: 27842552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oxidative stress-based therapeutics in COPD.
    Barnes PJ
    Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxidative and Nitrosative Stress in the Pathogenesis of Obstructive Lung Diseases of Increasing Severity.
    Di Stefano A; Maniscalco M; Balbi B; Ricciardolo FLM
    Curr Med Chem; 2020; 27(42):7149-7158. PubMed ID: 32496983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress.
    Couillard A; Prefaut C
    Eur Respir J; 2005 Oct; 26(4):703-19. PubMed ID: 16204604
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of oxidative stress in COPD: current concepts and perspectives.
    Cavalcante AG; de Bruin PF
    J Bras Pneumol; 2009 Dec; 35(12):1227-37. PubMed ID: 20126926
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease.
    Igishi T; Hitsuda Y; Kato K; Sako T; Burioka N; Yasuda K; Sano H; Shigeoka Y; Nakanishi H; Shimizu E
    Respirology; 2003 Dec; 8(4):455-60. PubMed ID: 14629648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.
    Kinnula VL
    Thorax; 2005 Aug; 60(8):693-700. PubMed ID: 16061713
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cellular and molecular mechanisms of chronic obstructive pulmonary disease.
    Barnes PJ
    Clin Chest Med; 2014 Mar; 35(1):71-86. PubMed ID: 24507838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease.
    Mancini A; Corbo GM; Gaballo A; Raimondo S; Di Segni C; Gigliotti P; Silvestrini A; Valente S; Littarru GP; Pontecorvi A; Meucci E
    Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):623-8. PubMed ID: 23073919
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease.
    Boukhenouna S; Wilson MA; Bahmed K; Kosmider B
    Oxid Med Cell Longev; 2018; 2018():5730395. PubMed ID: 29599897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
    Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
    Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antioxidant pharmacological therapies for COPD.
    Rahman I; MacNee W
    Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxidative stress in COPD: molecular background and clinical monitoring.
    Antus B; Kardos Z
    Curr Med Chem; 2015; 22(5):627-50. PubMed ID: 25585265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.